QL
PHAT icon

Quarry LP’s Phathom Pharmaceuticals PHAT Stock Holding History

Quarry LP’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38K Buy
+127
New +$1.45K ﹤0.01% 1834
2025
Q4 		– Sell
-7,007
Closed -$82.5K – 2498
2025
Q3 		$82.5K Buy
7,007
+5,983
+584% +$61.7K 0.02% 588
2025
Q2 		$9.82K Buy
+1,024
New +$5.67K ﹤0.01% 1342

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Quarry LP's PHAT Position: Q2 2026 in Review

Quarry LP opened a new position in Phathom Pharmaceuticals (PHAT) in Q2 2026: 127 shares worth $1.38K. The stake represents ﹤0.01% of the portfolio and ranks #1834 among its holdings. This is a return to the name: Quarry LP previously reported a position in PHAT as recently as Q3 2025.

Quarry LP first reported a position in PHAT in Q2 2025 and has held it in 3 quarters since. The position peaked at $82.5K in Q3 2025. 162 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

  • Quarry LP held 127 shares of Phathom Pharmaceuticals worth $1.38K as of Q2 2026.
  • Phathom Pharmaceuticals was a new Quarry LP position in Q2 2026.
  • Phathom Pharmaceuticals made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1834 holding.
  • Quarry LP first reported a position in Phathom Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • Quarry LP's Phathom Pharmaceuticals position peaked at $82.5K in Q3 2025.
  • 162 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.